Regenerative medicine (RM) is one of the most innovative technologies that might prove to have a significant added value in healthcare. I will start with some scientific definitions and then move into the business area. RM is an interdisciplinary field involving tissue engineering and (stem) cell therapy. Stem cells are undifferentiated cells (i.e. they have…… Continue reading Regenerative Medicine Market: The future in Life Sciences or just another promise?
As pharma celebrates its 16-year high NME approvals, productivity of certain disease areas including oncology certainly fall behind. Oncology diseases are the most complex in terms of research and development. At the research stage, target identification has been a major challenge due to the high toxicity of potential drug candidates. At the development stage, pharma…… Continue reading Oncology Market: Drivers and Challenges
A question that seeks answer in view of the challenges that the pharma industry is currently facing globally and specially in Europe. Pharma has to find ways in order to improve Research and Development (R&D) productivity by reducing development time frames, R&D costs and increasing the chances of success from pre-clinical phases to market launch.…… Continue reading Can biotech Mergers and Acquisitions save big pharma?